hotspot -WSS

hotspot

author：entertainment 2025-10-03 00:22:19 - browse：651

A sign of The Cigna Group in front of trees with orange and green leaves — insurance overage from STAT — Joe Buglewicz/Bloomberg

Cigna and Humana are in discussions to merge, a potential move that would create a health insurance and prescription drug benefits titan with approximately $300 billion of annual revenue.

A proposed transaction would almost certainly prompt a close review from antitrust enforcers at the Department of Justice and the Federal Trade Commission. A merged Cigna-Humana would further consolidate the market for pharmacy benefit managers. PBMs are companies that serve as the controversial middlemen of drug pricing negotiations, and of the four largest, two are owned by Cigna and Humana.

The Wall Street Journal first reported the talks between Cigna and Humana on Wednesday, citing sources close to the situation. Wendell Potter, a health insurance whistleblower who used to work at Cigna, also wrote about merger discussions between Cigna and Humana on his blog Tuesday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： CDC recommends rationing of RSV shot due to shortages

entertainment

WSS

Wegovy trial has doctors encouraged over new possibilities

The best solution to the drug shortages problem

Emergency medicine has repudiated 'excited delirium.' Now what?

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

Biden's order seeks to regulate AI risk without stifling innovation

Chimpanzees, like humans and whales, get menopause: Study

leisure time

hotspot

entertainment

Duchenne breakthrough therapy leaves behind pioneering families

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

New air purifier tech could be key to improving indoor air quality

Friends ask where James Watson's attitudes about race came from

Walensky prepares to leave CDC — and Congress — behind

What to know about Virgin Galactic's 1st mission taking paying customers to space

Dobbs anniversary: the lost opportunity of abortion as health care

Meta's Zuckerberg and Chan on track to put $50 billion into science

Activists slam private health insurers over coverage restrictions

The FDA weighs the risks of candy

focus

Traditional Chinese medicine benefits explored in new JAMA study

Readout Newsletter: New research from Sanofi, Regeneron, etc.

Emergent cuts jobs, executive role in business shake

Maker of FluMist seeks to allow at

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

hotspot

entertainment

hotspot

hotspot